Wordt geladen...
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis
BACKGROUND: Breast cancer tumor markers are used by some clinicians to screen for disease recurrence risk. Since there is limited evidence of benefit, additional research may be warranted. AIM: To assess the potential value of a randomized clinical trial of breast tumor marker testing in routine fol...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4018420/ https://ncbi.nlm.nih.gov/pubmed/24236631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cer.13.15 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|